Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Predictive Oncology ( (POAI) ).
On September 29, 2025, Predictive Oncology Inc. announced two private placements totaling $344.4 million to support its new digital asset treasury strategy, focusing on Aethir (ATH) tokens. This strategic move aims to enhance the company’s operations by leveraging Aethir’s decentralized GPU network, potentially strengthening its market position and offering significant growth opportunities. The company plans to use the proceeds to acquire ATH tokens and fund general corporate purposes, with DNA Holdings Venture, Inc. as a strategic advisor. This initiative marks a significant step in Predictive Oncology’s expansion into digital assets, aligning with its core business of AI-driven drug discovery.
The most recent analyst rating on (POAI) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Predictive Oncology stock, see the POAI Stock Forecast page.
Spark’s Take on POAI Stock
According to Spark, TipRanks’ AI Analyst, POAI is a Neutral.
The overall stock score is primarily impacted by significant financial challenges, including declining revenues and negative profit margins. Technical analysis provides some hope for a rebound, but the bearish trend remains strong. Valuation metrics are poor, with a negative P/E ratio and no dividend yield.
To see Spark’s full report on POAI stock, click here.
More about Predictive Oncology
Predictive Oncology is at the forefront of utilizing artificial intelligence and machine learning to accelerate early drug discovery and facilitate drug development, particularly for cancer treatment. The company boasts a scientifically validated AI platform, PEDAL, with a 92% accuracy rate in predicting tumor response to drug compounds. Headquartered in Pittsburgh, PA, Predictive Oncology offers one of the most comprehensive AI-based drug discovery solutions, supported by a vast biobank and a CLIA laboratory facility.
Average Trading Volume: 207,217
Technical Sentiment Signal: Strong Sell
Current Market Cap: $8.86M
For an in-depth examination of POAI stock, go to TipRanks’ Overview page.